DAY 2 | 90-second video highlights from the world’s largest cardiology conference
Professor David Brieger
| CANTOS – The Canakinumab Anti-Inflammatory Thrombosis Outcomes Study WATCH » |
| Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) trial: Primary Results WATCH » |
Associate Professor John Atherton
| Routine versus aggressive upstream rhythm control of early atrial fibrillation in heart failure, the RACE 3 study WATCH » |
| Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation: the CASTLE-AF trial WATCH » |
Dr Vivienne Miller
| Lipids in atherosclerosis - Evolving concepts WATCH » |
| Bioresorbable vascular scaffolds: still the future or already in the past? WATCH » |
Professor Phillip Newton
| GARDIAN of my heart: utility of traffic-light based tool to guide the intensity of nurse-led, multidisciplinary, heart failure management WATCH » |
| Matching delivery of heart failure management to overcome individual barriers to optimal health care: A case of so CLOSE and yet so far WATCH » |
The Cardiology Today delegates are independently selecting and curating their own sessions for this Australian coverage of ESC Congress 2017 direct from Barcelona.